Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded a glossary display option; updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the previous QC term Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check44 days agoChange DetectedThe Study Record Dates section now displays a concrete 'Last Update Posted' timestamp, replacing the previous 'Last Update Posted (Estimated)' label. This clarifies the timing of the update without altering the underlying study data.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.